Sofinnova Venture Partners IX, L.P. → Ascendis Pharma A/S ASND

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

8 13D/G filings on this issuer

7 other filings besides this one

Filer Track Record

8 filings by this filer

7 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 9.45

3,695,502 shares short · -4.0% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $28.33M

Point72 Asset Mgmt

Other 13D/G Filings on Ascendis Pharma A/S

Filed	Form	Filer	Stake	Shares
2020-03-05	SC	ORBIMED ADVISORS LLC	—	—	view →
2019-10-23	SC	VIVO VENTURES VII, LLC	—	—	view →
2019-08-14	SC	ORBIMED ADVISORS LLC	—	—	view →
2019-03-12	SC	ORBIMED ADVISORS LLC	—	—	view →
2019-02-12	SC	Sofinnova Venture Partners IX, L.P.	—	—	view →
2018-02-14	SC	Sofinnova Capital V FCPR	—	—	view →
2018-01-29	SC	ORBIMED ADVISORS LLC	—	—	view →

Other Filings by Sofinnova Venture Partners IX, L.P.

Filed	Form	Issuer	Stake	Shares
2021-03-04	SC	Entasis Therapeutics Holdings Inc.	—	—	view →
2020-06-05	SC	Iterum Therapeutics plc ITRMF	—	—	view →
2020-04-27	SC	Merus N.V.	—	—	view →
2020-01-27	SC	Iterum Therapeutics plc ITRMF	—	—	view →
2019-11-22	SC	NextCure, Inc. NXTC	—	—	view →
2019-02-12	SC	aTYR PHARMA INC ATYR	—	—	view →
2019-02-12	SC	Ascendis Pharma A/S ASND	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →